Anthony Digiandomenico, Director at Provention Bio, Inc. (PRVB), bought 25,000 shares at $12.16 ($304K) on 2019-06-17, disclosed to the SEC on 2019-06-17.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| MDBH | BUY | 2025-02-14 | $8K | — | Filing → |
| MDBH | BUY | 2025-02-11 | $12K | — | Filing → |
| MDBH | BUY | 2025-02-06 | $4K | — | Filing → |